Skip to main content
Gut logoLink to Gut
. 1996 Jul;39(1):5–8. doi: 10.1136/gut.39.1.5

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.

A van der Burgh 1, J Dees 1, W C Hop 1, M van Blankenstein 1
PMCID: PMC1383220  PMID: 8881798

Abstract

BACKGROUND: Barrett's oesophagus carries a 30-fold to 40-fold increased risk of oesophageal cancer. It is unknown whether endoscopic surveillance programmes reduce mortality from oesophageal cancer. METHODS: A cohort study was undertaken of all 166 patients in whom the diagnosis Barrett's oesophagus had been established between 1973 and 1986. RESULTS: One hundred and fifty five of 166 patients could be traced (93%). During a mean follow up of 9.3 years (amounting to 1440 patient years) eight patients had developed oesophageal cancer at random intervals (one case in 180 patient years). All but one of the tumours were diagnosed at endoscopy for symptoms, three in the stage of carcinoma in situ. Risk factors for the development of oesophageal cancer were extensive Barrett's oesophagus exceeding 10 cm (p = 0.02) and Barrett's ulcer at the time of intake (p = 0.009). Seventy six patients were alive; three had undergone surgery for oesophageal cancer and were without recurrence respectively, 12.8 years, 12.1 years, and 7 months postoperatively. Seventy nine patients had died; five of them had developed oesophageal cancer, but in only two cases this had been the cause of death (2.5%). CONCLUSIONS: Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. The patients of this cohort would not have benefited from an endoscopic surveillance programme.

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achkar E., Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol. 1988 Mar;83(3):291–294. [PubMed] [Google Scholar]
  2. Cameron A. J., Ott B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985 Oct 3;313(14):857–859. doi: 10.1056/NEJM198510033131404. [DOI] [PubMed] [Google Scholar]
  3. Hameeteman W., Tytgat G. N., Houthoff H. J., van den Tweel J. G. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989 May;96(5 Pt 1):1249–1256. doi: 10.1016/s0016-5085(89)80011-3. [DOI] [PubMed] [Google Scholar]
  4. Hamilton P. W., Bartels P. H., Montironi R., Anderson N., Thompson D. Improved diagnostic decision-making in pathology: do inference networks hold the key? J Pathol. 1995 Jan;175(1):1–5. doi: 10.1002/path.1711750102. [DOI] [PubMed] [Google Scholar]
  5. Iftikhar S. Y., James P. D., Steele R. J., Hardcastle J. D., Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. 1992 Sep;33(9):1155–1158. doi: 10.1136/gut.33.9.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Krishnadath K. K., van Blankenstein M., Tilanus H. W. Prognostic value of p53 in Barrett's oesophagus. Eur J Gastroenterol Hepatol. 1995 Jan;7(1):81–84. [PubMed] [Google Scholar]
  7. Menke-Pluymers M. B., Hop W. C., Dees J., van Blankenstein M., Tilanus H. W. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993 Aug 15;72(4):1155–1158. doi: 10.1002/1097-0142(19930815)72:4<1155::aid-cncr2820720404>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  8. Miros M., Kerlin P., Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut. 1991 Dec;32(12):1441–1446. doi: 10.1136/gut.32.12.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Reid B. J., Blount P. L., Rubin C. E., Levine D. S., Haggitt R. C., Rabinovitch P. S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology. 1992 Apr;102(4 Pt 1):1212–1219. [PubMed] [Google Scholar]
  10. Robertson C. S., Mayberry J. F., Nicholson D. A., James P. D., Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg. 1988 Aug;75(8):760–763. doi: 10.1002/bjs.1800750813. [DOI] [PubMed] [Google Scholar]
  11. Spechler S. J., Robbins A. H., Rubins H. B., Vincent M. E., Heeren T., Doos W. G., Colton T., Schimmel E. M. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 1984 Oct;87(4):927–933. [PubMed] [Google Scholar]
  12. Van der Veen A. H., Dees J., Blankensteijn J. D., Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut. 1989 Jan;30(1):14–18. doi: 10.1136/gut.30.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Williamson W. A., Ellis F. H., Jr, Gibb S. P., Shahian D. M., Aretz H. T., Heatley G. J., Watkins E., Jr Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med. 1991 Nov;151(11):2212–2216. doi: 10.1001/archinte.151.11.2212. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES